live attenuated measles virus vaccine
Term · Oncology and biomedicine · MLC-T-ONC-014851
A live, attenuated measles vaccine with potential antineoplastic activity. Upon subcutaneous administration, live attenuated measles virus vaccine may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against measles-positive tumor cells. Measles virus has been shown to be present in some non-small cell lung cancers.
| Identifier | MLC-T-ONC-014851 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014851",
"term": "live attenuated measles virus vaccine",
"field": "Oncology and biomedicine",
"definition": "A live, attenuated measles vaccine with potential antineoplastic activity. Upon subcutaneous administration, live attenuated measles virus vaccine may activate the immune system to mount a cytotoxic T-lymphocyte (CTL) response against measles-positive tumor cells. Measles virus has been shown to be present in some non-small cell lung cancers.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/live-attenuated-measles-virus-vaccine/"
}
Record 10,218 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.